Volpi Group’s Post

Amidst cost pressures and disruptive technologies, medtech companies are rethinking their strategies. Recent transformations highlight focus on core strengths, AI investments, and innovative deal structures. Key areas: digital value transformation, enterprise agility, and M&A strategy. Check out PwC’s latest report here: https://pwc.to/3Yoqgsk #MTC24 #MedtechIndustry #HealthcareTransformation #FutureGrowth

When the stakes are high and regulation is necessarily complex, using digital twins can enable better, faster innovation in MedTech. Unlocking the value available can be hard, but getting the transformation right can help organisations create better performing products. #digital #innovation #medtech Read on: https://ow.ly/vWQZ50RqkNr

Amidst cost pressures and disruptive technologies, medtech companies are rethinking their strategies. Recent transformations highlight focus on core strengths, AI investments, and innovative deal structures. Key areas: digital value transformation, enterprise agility, and M&A strategy. Check out PwC’s latest report here: https://pwc.to/3Yoqgsk #MTC24 #MedtechIndustry #HealthcareTransformation #FutureGrowth

Amidst cost pressures and disruptive technologies, medtech companies are rethinking their strategies. Recent transformations highlight focus on core strengths, AI investments, and innovative deal structures. Key areas: digital value transformation, enterprise agility, and M&A strategy. Check out PwC’s latest report here: https://pwc.to/3Yoqgsk #MTC24 #MedtechIndustry #HealthcareTransformation #FutureGrowth

Digital twins can drive faster innovation in complex #MedTech environments. Mastering this #transformation can help organizations create better products. Good read. #medtech #innovation #digitalinnovation #digitaltwins #valuecreation #innovationpipeline

2024 comes to an end – a good time to wish all our customers, partners, shareholders and employees Merry Christmas and an excellent start into 2025. May it be the best year ever! Apart from thanking you for your support in 2024 it is also time to look back and draw conclusions. Here are mine for ai6 solutions   1. Dynamic of consolidation of MedTech in general and European development and production services industry for MedTech (CDMO) in particular is substantially increasing. And everybody that sees this writing on the wall is talking to ai6 solutions as major buy and build platform in this space. 2. Seleon and LM4med joined and substantially increased the services that we can provide to MedTech customers 3. Innovation is still a key driver of Medtech and ai6 solutions has been trusted by customers to support their major innovations a. SASSE Elektronik GmbH as Technology platform innovator with safety wireless controls from Safety Remote Controls and SafetyPads to SafetyFootswitches supporting advanced useability concepts b. seleon GmbH as Medtech Expert Consulting innovator in major MedTech OEM M&A Due Dilligence projects supporting predictable transactions c.  SASSE Elektronik GmbH as development or production service provider for major Startup innovations like Cellbox Solutions, AGVOLUTION, and many more supporting them in shaping their markets  d.  seleon GmbH as technology development and regulatory process innovator for AI und Cloud-Integration of medical devices and Software as medical devices approvals supporting the IT revolution in healthcare e.  LM4med as time to market regulatory approval process innovator finding ways to lower the burden of the red tape   f.   FG Elektronik as battery management innovator increasing charging options for mobile medical devices and supporting mobile MedTech.    I wish you all relaxing holidays and see you all next year to work on the next level of healthcare. #MedTech #CDMO #developmentservices #productionservices #innovation #safety #RemoteControl #AI #Cloud #M&A #DueDilligence

When the stakes are high and regulation is necessarily complex, using digital twins can enable better, faster innovation in medtech. Unlocking the value available can be hard, but getting the transformation right can help organizations create better performing products. Find out more in the latest @McKinsey Operations blog.

When the stakes are high and regulation is necessarily complex, using digital twins can enable better, faster innovation in medtech. Unlocking the value available can be hard, but getting the transformation right can help organizations create better performing products. Find out more in the latest McKinsey Operations blog. #Medtech #DigitalTwins

Innovation remains imperative in the #MedTech industry, with 83% citing it as a top-three priority. Key challenges for MedTech innovators include talent pool constraints and unclear strategy. Despite this, 49% of MedTech firms are experimenting with #GenerativeAI for innovation. To transform these efforts into value, innovation systems need a reboot. Read the 2024 Most Innovative Companies Report to learn more: https://lnkd.in/eGDtYVvT

When the stakes are high and regulation is necessarily complex, using digital twins can enable better, faster innovation in medtech. Unlocking the value available can be hard, but getting the transformation right can help organizations create better performing products. Find out more in the latest @McKinsey Operations blog.